PERFORMANCE OF A NEW RISK ASSESSMENT TOOL FOR PATIENTS WITH METASTATIC RENAL CELL CARCINOMA UNDERGOING CYTOREDUCTIVE NEPHRECTOMY IN THE TARGETED THERAPY ERA: REMARCC SCORE | AVESİS

Istanbul University Research Information System

PERFORMANCE OF A NEW RISK ASSESSMENT TOOL FOR PATIENTS WITH METASTATIC RENAL CELL CARCINOMA UNDERGOING CYTOREDUCTIVE NEPHRECTOMY IN THE TARGETED THERAPY ERA: REMARCC SCORE

Copy For Citation

Carmen Mir M., Marchioni M., Campi R., Minervini A., Roussel E., Albertsen M., ...More

Annual Meeting of the American-Urological-Association (AUA), Washington, Kiribati, 15 - 18 May 2020, vol.203

Publication Type: Conference Paper / Summary Text
Volume: 203
City: Washington
Country: Kiribati
Istanbul University Affiliated: Yes